These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37804199)

  • 1. Uric Acid Levels, Number of Standard Modifiable Cardiovascular Risk Factors, and Prognosis in Patients With Coronary Artery Disease: A Large Cohort Study in Asia.
    Cui K; Song Y; Yin D; Song W; Wang H; Zhu C; Feng L; Fu R; Jia L; Lu Y; Zhang D; Song C; Yang Y; Dong Q; Dou K
    J Am Heart Assoc; 2023 Oct; 12(20):e030625. PubMed ID: 37804199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high level of uric acid is associated with long-term adverse cardiovascular outcomes in patients who received fractional flow reserve with coronary intermediate stenosis.
    Li F; Lin Q; Zhou J; Zhu J; Zhou Y; Wu K; Li Q; Zhao D; Liu Q
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1538-1545. PubMed ID: 38644080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
    Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study.
    He J; Bian X; Song C; Zhang R; Yuan S; Yin D; Dou K
    Cardiovasc Diabetol; 2022 Aug; 21(1):156. PubMed ID: 35964050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of obstructive sleep apnea on prognosis in patients with acute coronary syndromes with varying numbers of standard modifiable risk factors: insight from the OSA-ACS study.
    Wang B; Zhang Y; Hao W; Fan J; Yan Y; Gong W; Zheng W; Que B; Ai H; Wang X; Nie S
    J Thromb Thrombolysis; 2023 Jul; 56(1):65-74. PubMed ID: 37243941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ten-Year Follow-Up Study of the Association Between Uric Acid and Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
    Ndrepepa G; Kufner S; Cassese S; Joner M; Xhepa E; Wiebe J; Sager HB; Kessler T; Laugwitz KL; Schunkert H; Kastrati A
    Am J Cardiol; 2024 Apr; 216():19-26. PubMed ID: 38336081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?
    Eisen A; Benderly M; Goldbourt U; Haim M
    Clin Cardiol; 2013 Feb; 36(2):110-6. PubMed ID: 23335377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive Sleep Apnea and Cardiovascular Events After Percutaneous Coronary Intervention.
    Lee CH; Sethi R; Li R; Ho HH; Hein T; Jim MH; Loo G; Koo CY; Gao XF; Chandra S; Yang XX; Furlan SF; Ge Z; Mundhekar A; Zhang WW; Uchôa CH; Kharwar RB; Chan PF; Chen SL; Chan MY; Richards AM; Tan HC; Ong TH; Roldan G; Tai BC; Drager LF; Zhang JJ
    Circulation; 2016 May; 133(21):2008-17. PubMed ID: 27178625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors - rationale and design of the "Beyond-SMuRFs Study".
    Moysidis DV; Daios S; Anastasiou V; Liatsos AC; Papazoglou AS; Karagiannidis E; Kamperidis V; Makedou K; Thisiadou A; Karalazou P; Papadakis M; Savopoulos C; Ziakas A; Giannakoulas G; Vassilikos V; Giannopoulos G
    BMC Cardiovasc Disord; 2023 Mar; 23(1):149. PubMed ID: 36959584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
    Wang P; Yuan D; Zhang C; Zhu P; Jia S; Song Y; Tang X; Xu J; Li T; Zeng G; Zhao X; Yang Y; Xu B; Gao R; Yuan J
    Cardiovasc Diabetol; 2022 Mar; 21(1):46. PubMed ID: 35313877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of fibrinogen-to-albumin ratio combined with coronary calcification score in patients with suspected coronary artery disease.
    Tian XX; Luo JY; Liu F; Qiu YJ; Luo F; Zeng L; Zhang ZR; Yang YN; Li XM
    BMC Cardiovasc Disord; 2023 Apr; 23(1):181. PubMed ID: 37016312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study.
    Perticone M; Maio R; Shehaj E; Gigliotti S; Caroleo B; Suraci E; Sciacqua A; Andreozzi F; Perticone F
    Cardiovasc Diabetol; 2023 Nov; 22(1):298. PubMed ID: 37915077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid is an independent predictor of cardiovascular events in post-menopausal women.
    Sciacqua A; Perticone M; Tassone EJ; Cimellaro A; Miceli S; Maio R; Sesti G; Perticone F
    Int J Cardiol; 2015 Oct; 197():271-5. PubMed ID: 26142972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Hauser C; Farhan S; Freynhofer MK; Huber K; Weiss TW
    Atherosclerosis; 2018 Mar; 270():173-179. PubMed ID: 29432935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.
    Kawabe M; Sato A; Hoshi T; Sakai S; Hiraya D; Watabe H; Kakefuda Y; Ishibashi M; Abe D; Takeyasu N; Aonuma K
    J Cardiol; 2016 Feb; 67(2):170-6. PubMed ID: 26228000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Nicholls SJ; Chow CK; Psaltis P; Røsjø H; Leósdóttir M; Hagström E
    J Am Heart Assoc; 2022 Aug; 11(15):e024818. PubMed ID: 35876409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery.
    Lazzeroni D; Bini M; Camaiora U; Castiglioni P; Moderato L; Bosi D; Geroldi S; Ugolotti PT; Brambilla L; Brambilla V; Coruzzi P
    Eur J Prev Cardiol; 2018 Jan; 25(2):119-126. PubMed ID: 29164926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.